Article Text
Matters arising
Treatment with calcitonin for osteoporosis
Statistics from Altmetric.com
I would like the opportunity to correct, or possibly update, a number of the facts concerning calcitonin contained in Dr Patel’s comprehensive review article on drug treatments for osteoporosis.1
He states that nasal preparations of calcitonin are licensed for use in osteoporosis in ‘some European countries and Japan’, whereas in fact the nasal spray formulation of salmon calcitonin developed at Sandoz (now Novartis) is currently approved in more than 70 countries worldwide, including the USA and almost all the countries of Europe. Japan, …
Linked Articles
- Research Article